Ann Chartrand
Psychiatric/Mental Health · Colorado Springs, CONPI 1336678366
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 387 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,885 and has fallen 92.5% since, to $215 in 2025. Among psychiatric/mental health clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 387 payments — averaging $17.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Validus Pharmaceuticals LLC$689
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$490
- Otsuka America Pharmaceutical, Inc.$476
- Axsome Therapeutics, Inc.$366
- Takeda Pharmaceuticals U.S.A., Inc.$332
- plus $3K from 27 others
What the payments were for
- Food & beverage$6,58299%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 83 | $1,151 |
| Validus Pharmaceuticals LLC | 6 | $689 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 36 | $490 |
| Otsuka America Pharmaceutical, Inc. | 35 | $476 |
| Axsome Therapeutics, Inc. | 24 | $366 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $332 |
| Corium, LLC | 18 | $306 |
| Bausch Health US, LLC | 20 | $292 |
| Lundbeck LLC | 14 | $284 |
| Johnson & Johnson | 12 | $230 |
| Sunovion Pharmaceuticals Inc. | 12 | $199 |
| Alkermes, Inc. | 10 | $193 |
| Harmony Biosciences LLC | 5 | $178 |
| Vanda Pharmaceuticals Inc. | 8 | $173 |
| Neurocrine Biosciences, Inc. | 9 | $161 |
| Teva Pharmaceuticals USA, Inc. | 7 | $126 |
| Supernus Pharmaceuticals, Inc. | 7 | $117 |
| Avanir Pharmaceuticals, Inc. | 8 | $115 |
| Merck | 7 | $111 |
| Jazz Pharmaceuticals Inc. | 6 | $87 |
| Tris Pharma Inc | 5 | $83 |
| Novo Nordisk | 4 | $70 |
| Acadia Pharmaceuticals Inc | 4 | $69 |
| Neos Therapeutics, LP | 3 | $67 |
| Ironshore Pharmaceuticals Inc. | 4 | $58 |
| Adlon Therapeutics L.p. | 3 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Sage Therapeutics, LLC | 2 | $35 |
| Eisai Inc. | 2 | $32 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| OWP Pharmaceuticals, Inc. | 1 | $16 |
| Livanova USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Equetro$552
How this compares
$6,627 in reported general payments places this provider in the 95th percentile of 873 psychiatric/mental health providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 18 | $13,523 |
| BelsomraSuvorexant | 14 | $6,054 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 12 | $1,137 |
| Memantine Hcl | 20 | $381 |
| Guanfacine Hcl ErGuanfacine Hcl | 11 | $266 |
| Bupropion XlBupropion Hcl | 12 | $226 |
| Duloxetine Hcl | 12 | $181 |
| Lamotrigine | 21 | $172 |
| Alprazolam | 39 | $145 |
| Clonazepam | 12 | $119 |
| Escitalopram Oxalate | 16 | $115 |
| Trazodone Hcl | 13 | $107 |
| Buspirone Hcl | 24 | $76 |
| Quetiapine Fumarate | 12 | $31 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $332 | $13,52318 claims |
| MerckBelsomra | $111 | $6,05414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 873 psychiatric/mental health providers in Colorado.
Other psychiatric/mental health in Colorado Springs
- Mark JankelowColorado Springs$287K
- Cristi BundukamaraColorado Springs$230K
- Jennie StormesColorado Springs$12K
- Kimberly SmithColorado Springs$9K
- Lewis SwarthoutColorado Springs$7K
- Kristin MagnusonColorado Springs$7K
- Shannon GravesColorado Springs$6K
- Alison BakerColorado Springs$6K
- Patricia BursnallColorado Springs$5K
- Kayla PrevidiColorado Springs$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.